Total (n = 34) Group I (n = 26) Group II (n = 8) P value
Age, median [IQR], year 64.50 [61.00,69.00] 63.00 [57.00,69.00] 69.00 [67.00,69.00] 0.04*
Sex 0.03*
Female, No. (%) 11(32.40) 11 (42.30) 0 (0.00)
Male, No. (%) 23 (67.60) 15 (57.70) 8 (100.00)
Highest temperature, mean ± SD, ℃ 38.52 ± 0.73 38.57 ± 0.73 38.36 ± 0.76 0.98
Comorbidities
Cardiovascular diseases, No. (%) 8 (23.50) 7 (26.90) 1 (12.50) 0.65
Hypertension, No. (%) 12 (35.30) 7 (26.90) 5 (62.50) 0.10
Diabetes, No. (%) 10 (29.40) 8 (30.80) 2 (25.00) 1.00
Chronic kidney disease, No. (%) 1 (2.90) 1 (3.80) 0 (0.00) 1.00
COPD, No. (%) 1 (2.90) 0 (0.00) 1 (12.50) 0.24
Tuberculosis, No. (%) 34 (100.0) 26 (100.0) 8 (100.0) -
Malignant tumor, No. (%) 1 (2.90) 0 (0.00) 1 (12.50) 0.24
Myoglobin, μg/L 67.77 [32.25,161.07] 56.93 [30.19,98.79] 227.82 [195.36.1,11916.36] <0.01**
Interleukin 6, pg/ml 29.05 [6.03,78.77] 12.02 [5.26,43.70] 78.77 [61.13,114.64] 0.01*
Creatine kinase, U/L 45.70 [27.00,193.38] 53.00 [39.00,93.00] 70.00 [43.50,345.50] 0.77
D-dimer, μg/L 4.75 ± 6.29 2.70 ± 4.15 10.89 ± 7.81 <0.01**
Troponin I, ng/mL 0.018 [0.007,0.078] 0.026 [0.006,0.087] 0.069 [0.048,0.094] 0.02*
Procalcitonin, ng/mL 0.20 [0.13,0.28] 0.22 [0.15,0.27] 0.12 [0.12,0.15] 0.09
C-reactive protein, mg/L 64.99 ± 67.22 49.08 ± 63.48 121.85 ± 49.03 0.73
BNP, pg/L 5.81 [2.21,37.11] 3.33 [1.79,5.46] 11.23 [8.70,63.22] 0.18
LVEF, % 62.74 ± 4.36 62.08 ± 4.36 64.88 ± 3.83 0.62
LVDd, mm 45.50 [43.25,48.00] 46.50 [44.00,49.00] 40.00 [39.50,40.00] 0.14
IVSd, mm 10.50 [10.0,12.00] 10.00 [10.00,10.00] 14.00 [13.50,15.00] <0.01**
PaO2:FiO2 253.33 ± 122.86 289.52 ± 106.98 135.74 ± 98.06 0.58
PASP, mmHg 33.06 ± 18.51 24.27 ± 7.70 61.63 ± 13.53 <0.01*